suprefact depot 3-months
sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).
suprefact 100 mcg/dose nasal spray solution
sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues
suprecur 150micrograms/dose nasal spray
neon healthcare ltd - buserelin acetate - spray - 150microgram/1dose
suprecur 150 micrograms/ metered dose nasal spray, solution
sanofi-aventis ireland limited t/a sanofi - buserelin - nasal spray, solution - 150 microgram(s) - gonadotropin releasing hormone analogues; buserelin
suprefact depot 2 months
sanofi - aventis israel ltd - buserelin acetate 6.6 mg - rods for implant - buserelin - treatment of advanced hormone - dependent prostatic carcinoma.
suprefact nasal spray
sanofi - aventis israel ltd - buserelin as acetate 0.1 mg/actuations - solution - buserelin - treatment of advanced hormone dependent prostatic carcinoma. endometriosis. use in ivf. precocious puberty. leyomyoma uteri.
suprefact injectable 1 mg/ml
sanofi-aventis singapore pte. ltd. - buserelin acetate eqv buserelin - injection - 1 mg/ml
suprecur solution for injection 1mg/ml
jv healthcare limited - buserelin - solution for injection - buserelin 1 milligram(s)/millilitre - endocrine therapy
suprefact nasal spray solution
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - buserelin - nasal spray, solution - buserelin 100 µg - endocrine therapy
suprefact inj 1mg/ml liquid
hoechst canada inc. - buserelin (buserelin acetate) - liquid - 1mg - buserelin (buserelin acetate) 1mg - miscellaneous therapeutic agents